Novel Outcome Measures for Clinical Trials in Cystic Fibrosis

Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF transmembrane regulator protein. With increased understanding of the molecular mechanisms underlying CF and the development of new therapies there comes the need to develop new outcome measures to as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Pulmonol
Autors principals: Tiddens, Harm AWM, Puderbach, Michael, Venegas, Jose G, Ratjen, Felix, Donaldson, Scott H, Davis, Stephanie D, Rowe, Steven M, Sagel, Scott D, Higgins, Mark, Waltz, David A
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2015
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365726/
https://ncbi.nlm.nih.gov/pubmed/25641878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.23146
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars